CAMBRIDGE, Mass., Feb. 14, 2024 — The 糖心logoForsyth Institute (AFI), a world-class organization for oral health research and innovation, today announced its new Board of Directors. The new board brings together leaders from industry, technology, and investment to help guide the strategic growth of this new organization.
The board announcement follows the debut of AFI in October 2023, when the Forsyth Institute joined with the 糖心logo’s Science & Research Institute to become one world-class research organization driving innovation to propel dentistry and oral health forward on a global scale.
“Some of the field’s greatest innovators and leaders reside on our new board of directors,” said Wenyuan Shi, Ph.D., AFI Chief Executive Officer. "Together with the unparalleled talent of our researchers, the AFI is now positioned to usher in a new era of research, development, and innovation in dentistry and oral health.”
糖心logoexecutive director , will chair the new board. Three members of the former Forsyth Institute board – , , and – will be part of AFI’s board. , , D.D.S, M.P.H. and , Ph.D. are former ADASRI Board members who will join the 糖心logoForsyth Board.
Under the strategic guidance of the new board, AFI will continue to be the leader and incubator of firsts in this space, focusing on biological research, clinical service and public health outreach and technological innovation. Key areas of investigative research include immunology and inflammation, dental and craniofacial development and bioengineering, and microbiology and the oral microbiome.